0.00
price down icon100.00%   -90.00
after-market Dopo l'orario di chiusura: 88.97 88.97 +
loading

Merus N V Borsa (MRUS) Ultime notizie

pulisher
Mar 05, 2026

Dividend Watch: Is Merus NV being accumulated by smart moneyMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 05, 2026
pulisher
Feb 25, 2026

Merus N.V. (MRUS) Stock Analysis: Potential Upside In The Biotech Sector - DirectorsTalk Interviews

Feb 25, 2026
pulisher
Feb 24, 2026

Wells Fargo Downgrades Merus N.V. (MRUS) - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

Aug Summary: Is Merus NV a good ESG investment2025 Big Picture & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 17, 2026

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem With 7.78% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026
pulisher
Feb 16, 2026

Bank of America Securities Maintained a Buy Rating on Merus N.V (MRUS) - MSN

Feb 16, 2026
pulisher
Feb 16, 2026

What is Merus N.V. s 5 year growth outlookWeekly Stock Summary & AI Enhanced Trading Signals - mfd.ru

Feb 16, 2026
pulisher
Feb 13, 2026

Targets Report: Will Merus N.V. stock outperform tech sector in 2025Weekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Genmab Prepares For Two Product Launches In 2027, Both From Recent Deals - Citeline News & Insights

Feb 12, 2026
pulisher
Feb 10, 2026

Is Merus N.V. stock trading near support levelsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru

Feb 10, 2026
pulisher
Feb 10, 2026

Published on: 2026-02-10 12:58:35 - mfd.ru

Feb 10, 2026
pulisher
Feb 06, 2026

Can Merus N.V. reach all time highs this year2025 Major Catalysts & Proven Capital Preservation Methods - mfd.ru

Feb 06, 2026
pulisher
Feb 03, 2026

Merus N.V. (MRUS) Stock Analysis: Weighing The 7.78% Potential Upside For Investors - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Jan 27, 2026

Merus N.V. (MRUS) Stock Analysis: Exploring the Potential 7.78% Upside in the Biotech Sector - DirectorsTalk Interviews

Jan 27, 2026
pulisher
Jan 25, 2026

Analyst Downgrade: Is Merus NV gaining market shareJuly 2025 Macro Moves & Daily Stock Momentum Reports - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Growth Recap: What are Can Fite BioPharma Ltd Depositary Receipts technical support levels - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 24, 2026

Aug Ideas: Is Merus NV a turnaround storyJuly 2025 PreEarnings & AI Enhanced Execution Alerts - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 21, 2026

Fourteen option delistings on January 21st - TipRanks

Jan 21, 2026
pulisher
Jan 20, 2026

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator With 7.78% Upside Potential - DirectorsTalk Interviews

Jan 20, 2026
pulisher
Jan 18, 2026

Piper Sandler sets $84 target on Merus stock, cites drug potential - MSN

Jan 18, 2026
pulisher
Jan 18, 2026

S P Trends: How does Merus NV correlate with Nasdaq2025 Technical Overview & Target Return Focused Picks - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 14, 2026

Merus N.V. (MRUS) Stock Analysis: Healthcare Innovator With 7.78% Upside Potential - DirectorsTalk Interviews

Jan 14, 2026
pulisher
Jan 13, 2026

Gap Down: Is Merus N.V. stock a safe haven assetJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Aug Breakouts: Why Merus NV stock could benefit from AI revolutionJuly 2025 Final Week & Stock Market Timing Techniques - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Risk Report: Will Merus NV stock benefit from M A activityQuarterly Market Summary & Pattern Based Trade Signal System - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Aug Shorts: Is Merus NV stock a buy on dipsEarnings Growth Summary & Low Risk Entry Point Tips - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

(MRUS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Jan 12, 2026
pulisher
Jan 12, 2026

Published on: 2026-01-13 00:53:02 - Улправда

Jan 12, 2026
pulisher
Jan 09, 2026

Merus N.V.Common Shares (NQ: MRUS - FinancialContent

Jan 09, 2026
pulisher
Jan 08, 2026

How Merus N.V. stock trades before earnings2025 Market Overview & Weekly Chart Analysis and Trade Guides - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Net current asset value per share of Merus N.V. – MUN:2GH - TradingView — Track All Markets

Jan 08, 2026
pulisher
Jan 08, 2026

Why Merus N.V. stock attracts high net worth investorsQuarterly Performance Summary & Reliable Entry Point Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Merus N.V. (2GH) stock positioned for digital growth eraDay Trading Setups & Free Tools to Monitor Market Corrections - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

Merus N.V. Financial Disclosures & Filings - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 06, 2026

Merus N.V. (MRUS) Stock Analysis: Exploring a 7.78% Potential Upside Amid Biotech Innovations - DirectorsTalk Interviews

Jan 06, 2026
pulisher
Jan 04, 2026

Genmab Announces $2.5 Billion Note Offering for Merus Acquisition - MSN

Jan 04, 2026
pulisher
Jan 02, 2026

What analysts say about Merus NV stockTrading Volume Surges & Outstanding Investment Returns - earlytimes.in

Jan 02, 2026
pulisher
Jan 01, 2026

Retail Trends: How Merus NV 2GH stock moves in volatile trading sessionsProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn

Jan 01, 2026
pulisher
Jan 01, 2026

Why retail investors favor Merus N.V. stockEconomic Indicators Overview & Low Risk Capital Growth Plans - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Moody Aldrich Partners LLC Reduces Position in Merus N.V. $MRUS - MarketBeat

Jan 01, 2026
pulisher
Dec 31, 2025

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus - ts2.tech

Dec 31, 2025
pulisher
Dec 30, 2025

A/S Genmab Purchases 1,052,806 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout - ts2.tech

Dec 30, 2025
pulisher
Dec 30, 2025

Genmab completes acquisition of Merus and delists shares from Nasdaq By Investing.com - Investing.com Australia

Dec 30, 2025
pulisher
Dec 30, 2025

Merus Completes Genmab Acquisition and Delists From Nasdaq - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Merus completes Genmab acquisition and delists from Nasdaq - MSN

Dec 30, 2025
pulisher
Dec 30, 2025

Genmab completes acquisition of Merus and delists shares from Nasdaq - Investing.com

Dec 30, 2025
pulisher
Dec 30, 2025

Merus Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Simplify Asset Management Inc. Takes $3.14 Million Position in Merus N.V. $MRUS - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Genmab to discontinue further development of acasunlimab - Yahoo Finance

Dec 30, 2025
pulisher
Dec 29, 2025

Merus (NASDAQ:MRUS) Major Shareholder A/S Genmab Acquires 96,082 Shares - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Acquires 142,610 Shares of Stock - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

A/S Genmab Purchases 561,042 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Purchases 15,710 Shares of Stock - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Merus N.V.(NasdaqGM: MRUS) dropped from NASDAQ Composite Index - MarketScreener

Dec 29, 2025
pulisher
Dec 29, 2025

Merus (NASDAQ:MRUS) Stock Price Down 7%Here's Why - MarketBeat

Dec 29, 2025
pulisher
Dec 28, 2025

Fed Watch: Why Merus NV 2GH stock stays undervaluedLong Setup & Weekly Breakout Watchlists - moha.gov.vn

Dec 28, 2025
pulisher
Dec 27, 2025

Merus N.V. (NASDAQ:MRUS) Sees Large Decrease in Short Interest - MarketBeat

Dec 27, 2025
pulisher
Dec 26, 2025

Stock Traders Buy High Volume of Call Options on Merus (NASDAQ:MRUS) - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Harbor Capital Advisors Inc. Trims Stock Holdings in Merus N.V. $MRUS - MarketBeat

Dec 26, 2025
$98.40
price down icon 1.24%
$28.78
price down icon 3.16%
$52.52
price down icon 2.43%
$101.50
price down icon 0.44%
$140.13
price down icon 2.40%
biotechnology ONC
$301.12
price up icon 2.79%
Capitalizzazione:     |  Volume (24 ore):